↓ Skip to main content

Fidaxomicin for treatment of Clostridium difficile infection in clinical practice: a prospective cohort study in a French University Hospital

Overview of attention for article published in Infection, January 2017
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
31 Mendeley
Title
Fidaxomicin for treatment of Clostridium difficile infection in clinical practice: a prospective cohort study in a French University Hospital
Published in
Infection, January 2017
DOI 10.1007/s15010-017-0981-8
Pubmed ID
Authors

Marie Pichenot, Rozenn Héquette-Ruz, Remi Le Guern, Bruno Grandbastien, Clément Charlet, Frédéric Wallet, Sophie Schiettecatte, Fanny Loeuillet, Benoit Guery, Tatiana Galperine

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 31 100%

Demographic breakdown

Readers by professional status Count As %
Other 5 16%
Student > Master 5 16%
Student > Postgraduate 3 10%
Professor > Associate Professor 3 10%
Student > Ph. D. Student 3 10%
Other 6 19%
Unknown 6 19%
Readers by discipline Count As %
Medicine and Dentistry 13 42%
Immunology and Microbiology 2 6%
Biochemistry, Genetics and Molecular Biology 1 3%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Unspecified 1 3%
Other 4 13%
Unknown 9 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 January 2017.
All research outputs
#15,708,956
of 26,017,215 outputs
Outputs from Infection
#999
of 1,636 outputs
Outputs of similar age
#231,527
of 428,564 outputs
Outputs of similar age from Infection
#4
of 17 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,636 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.7. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 428,564 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.